EE559 The Economic Impact of Reducing Bleeding With Emicizumab in Patients With Hemophilia A and Factor VIII Inhibitors – Brazilian Case

Abstract

Authors

N Segre V Mata TDC Martins

Full Text Cite This Article
Back to Volume 25, Supplemental Issue 12S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×